DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

Johnson & Johnson (NYSE: JNJ)



company name or ticker
Company Photos
(Click to zoom)

UPDATE: Bank Of America Reiterates On Johnson & Johnson On Likely EPS Headwinds

Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog

Retirement Strategy: Johnson & Johnson Did WHAT Today?

Why Dividend Stocks Routinely Dominate The World's 'Most Valuable Brands'

The 4 DJIA Stocks That Kept the Index Flat

J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog

J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog

Johnson & Johnson Conference Call Highlights

Dow Movers: JNJ, CAT

Johnson & Johnson Earnings: Pharmaceutical Sales Again Lead the Way

Johnson & Johnson earnings top Wall Street estimates once again as strong pharmaceutical sales growth, led primarily by new drugs, helped offset negative currency translation and the loss of revenue from divested operational segments.

Deutsche Bank Says Gilead Sciences Stock Reaction Is Overdone

See More Articles...